Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Terminated 2 Withdrawn 1 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4 Urinary Bladder Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Appendiceal Neoplasms 2 Urothelial Carcinoma Ureter 1 Peritoneal Neoplasms 1 Peritoneal Diseases 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Carcinoma, Transitional Cell 1 Carcinoma in Situ 1

Interventions

Gemcitabine 21 130-nm albumin-bound paclitaxel 8 irinotecan sucrosofate 7 Oxaliplatin 7 Leucovorin 7 Fluorouracil 7 Taxes 5 Drug Therapy 5 Albumin-Bound Paclitaxel 4 toripalimab 3 Specimen Handling 3 S 1 (combination) 3 Paclitaxel 3 Irinotecan 3 Injections 3 zimberelimab 2 surufatinib 2 camrelizumab 2 Pemetrexed 2 Pancreaticoduodenectomy 2 Magnetic Resonance Spectroscopy 2 Exercise 2 Capecitabine 2 Blood Specimen Collection 2 Biopsy 2 trastuzumab deruxtecan 1 sintilimab 1 semaglutide 1 potassium oxonate 1 pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Pancreatic Neoplasms × Mitomycin × Clear all

NCT06233877 2024-02-28

GFLIPM

Hirschfeld Oncology

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡